Sargent Bickham Lagudis LLC Idexx Laboratories Inc Transaction History
Sargent Bickham Lagudis LLC
- $1.22 Billion
- Q4 2022
A detailed history of Sargent Bickham Lagudis LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 215 shares of IDXX stock, worth $107,650. This represents 0.01% of its overall portfolio holdings.
Number of Shares
215
Previous 166
29.52%
Holding current value
$107,650
Previous $54,000
61.11%
% of portfolio
0.01%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding IDXX
# of Institutions
1,200Shares Held
75.5MCall Options Held
176KPut Options Held
284K-
Vanguard Group Inc Valley Forge, PA9.7MShares$4.85 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$4.81 Billion0.11% of portfolio
-
State Street Corp Boston, MA3.63MShares$1.82 Billion0.08% of portfolio
-
Alliancebernstein L.P. New York, NY3.14MShares$1.57 Billion0.55% of portfolio
-
Terry Smith Fundsmith LLP | London, X02.66MShares$1.33 Billion5.41% of portfolio
About IDEXX LABORATORIES INC
- Ticker IDXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 83,253,696
- Market Cap $41.7B
- Description
- IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...